唯赛勃: 唯赛勃2025年半年度报告

Core Viewpoint - The report highlights the financial performance and operational strategies of Shanghai Weisaibo New Materials Co., Ltd. for the first half of 2025, indicating a slight increase in revenue but a significant decline in net profit compared to the previous year [1][3]. Financial Performance - The company reported a revenue of CNY 185,049,271.24, representing a 0.27% increase from CNY 184,557,459.69 in the same period last year [3]. - Total profit decreased by 17% to CNY 15,071,986.43 from CNY 18,159,246.80 [3]. - Net profit attributable to shareholders fell by 19.3% to CNY 15,011,063.20 from CNY 18,600,816.69 [3]. - The net cash flow from operating activities increased significantly by 276.9% to CNY 29,967,597.38 from CNY 7,951,124.33 [3]. Business Overview - The company specializes in high-performance membrane separation technology, focusing on the research, production, and sales of reverse osmosis membranes and nanofiltration membranes [4][5]. - The company aims to become a leading supplier of core components in membrane separation technology, with applications in water treatment, municipal water supply, wastewater treatment, seawater desalination, and ultra-pure water preparation [4][5]. Industry Context - The membrane materials industry is a strategic emerging industry supported by national policies, with rapid development and increasing domestic market share [4][5]. - The company faces competition from established international players in the high-performance membrane sector, particularly from the USA and Japan [4][5]. Research and Development - The company invested CNY 1,475,040 in R&D during the first half of 2025, accounting for 7.97% of its revenue, a slight decrease from 8.05% in the previous year [5]. - The company has a total of 244 intellectual property applications, with 187 granted, indicating a strong focus on innovation [5][6]. Market Expansion - The company is actively expanding its market presence across various sectors, including chemicals, power, food and beverage, and pharmaceuticals, to capture growth opportunities [6][7]. - It aims to enhance its sales network and customer relationships to increase brand recognition and market influence [6][7]. Competitive Advantages - The company possesses advanced technology and a comprehensive product range, including various types of membranes and pressure vessels, which positions it favorably in the market [7][8]. - It has established long-term partnerships with well-known international companies, enhancing its market credibility [8].